The CY2019 Proposed Rule for Medicare Advantage and Medicare Prescription Drug Benefit Programs
Webinar | 12.12.17, 8:00 AM EST - 9:30 AM EST
CMS issued the long-awaited proposed rule that would make major changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs. CMS proposes many changes that are intended to increase transparency and alleviate administrative burdens on MA organizations and Part D sponsors. Other changes implement the Comprehensive Addiction and Recovery Act and the 21st Century Cures Act. CMS also solicits comments on a number of important topics.
Please join us for a webinar during which members of our Health Care Group discuss some of the key provisions of the proposed rule.
Provisions that we will address include:
- Implementation of the Comprehensive Addiction and Recovery Act of 2016
- New Benefit Flexibility under Medicare Advantage
- Tiering and Other Part D Changes
- Changes to the Star Ratings Program and the Impact for Contract Consolidation
- Changes to the Part C and Part D Medical Loss Ratio Requirements
Contact
Participants

- Washington, D.C.
- D | +1.202.624.2683
Insights
Webinar | 05.14.26
Because of recent changes to Federal and State law regulations, companies that manufacture, import, sell, or distribute products or equipment with components that contain certain “PFAS” materials face imminent and overlapping compliance obligations. This webinar will provide actionable information companies can use to determine whether they are impacted by these State and Federal requirements as well as practical advice for complying with these obligations. Topics that will be covered include the following:
Webinar | 29 April 2026, 3:00-4:30 pm CEST
Webinar | 04.21.26
From Covert to Kinetic: Escalating Cyber Threats in a Time of Conflict
